Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
134.75
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Apogee Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Hold Maintains $135 | Hold | Maintains | $135 | +0.19% | Aug 13, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $81 → $135 | Hold | Maintains | $81 → $135 | +0.19% | Aug 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Reiterates $135 | Hold | Reiterates | $135 | +0.27% | Aug 11, 2026 |
| Wedbush | Wedbush | Hold Maintains $135 | Hold | Maintains | $135 | +0.19% | Aug 11, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $135 | Hold | Maintains | $135 | +0.19% | Aug 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $133 | Buy | Maintains | $133 | -1.30% | Jun 29, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Downgrades $110 → $135 | Hold | Downgrades | $110 → $135 | +0.19% | Jun 24, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 23, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.